At the same time, some unique isoforms in exhausted T cells are related to poor prognosis, such as WARS and CCND3. Therefore, altering the isoform preference of specific genes in T cells may be an attractive avenue for improving cancer immunotherapy. Here, WARS1 is linked to cancer.